药明康德 港股通 空最新增减持 (2025-12-05) 官网 ( 02359.hk) | 19.44 | 4.01 | 1.68% | 上市时间2018-12-13股价104.30港币涨跌幅-0.29%成交金额5.02亿港币换手率0.16%市值3,112.06亿港币H股市值532.43亿港币总股本29.84亿H股本5.10亿每手股数100上市至今年化投资收益率21.76%港股通持仓占H股比例15.53% (81.65亿港币2025-12-05) 累计做空占H股比例6.85% (35.40亿港币2025-11-28) | |||
| 所属三级行业生物技术 (恒生) | 市盈率 | 65.79 | 市净率 | 4.99 | 股息率 | 0.31% | 恒生:医疗保健业药品及生物科技生物技术 |
| 所属指数指数纳入纳出 | |||||||
| 同股同权 | 查看历史折扣 | ||||||
| 备注 (6): | 双击编辑备注 |
药明康德(02359) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 盧韶華 | Independent Non Executive Director - A/F | 2023-05-31 | -- | |
| 2 | 俞衛 | Independent Non Executive Director | 2023-05-31 | -- | |
| 3 | 詹智玲 | Independent Non Executive Director | 2023-05-31 | -- | |
| 4 | 張新 | Independent Non Executive Director | 2023-05-31 | -- | |
| 5 | 陳民章 | Executive Director | CEO | 2022-05-06 | -- |
| 6 | 杨青 | Executive Director | CEO | 2020-05-15 | -- |
| 7 | 馮岱 | Independent Non Executive Director | 2018-08-22 | -- | |
| 8 | 蔡江南 | Independent Non Executive Director | 2017-03-17 | 2023-05-31 | |
| 9 | 劉艷 | Independent Non Executive Director | 2017-03-17 | 2023-05-31 | |
| 10 | 胡正國 | Executive Director | 2017-03-01 | -- | |
| 11 | 李革 | Executive Director | Chairman, CEO | 2017-03-01 | -- |
| 12 | 童小幪 | Non Executive Director | 2017-03-01 | -- | |
| 13 | 吳亦兵 | Non Executive Director | 2017-03-01 | -- | |
| 14 | 張朝暉 | Executive Director | 2017-03-01 | -- | |
| 15 | 婁賀統 | Independent Non Executive Director | 2017-03-01 | 2023-05-31 | |
| 16 | 張曉彤 | Independent Non Executive Director | 2017-03-01 | 2023-05-31 | |
| 17 | 趙寧 | Executive Director | 2017-03-01 | 2023-05-16 | |
| 18 | 劉曉鐘 | Executive Director | 2017-03-01 | 2020-03-24 |